Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (2) , 259-268
- https://doi.org/10.1016/s0091-6749(00)90074-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young childrenAnnals of Allergy, Asthma & Immunology, 1999
- Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthmaJournal of Allergy and Clinical Immunology, 1998
- Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroidsEuropean Respiratory Journal, 1998
- Growth in asthmatic children treated with fluticasone propionateThe Journal of Pediatrics, 1998
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Linear growth of very young asthmatic children treated with high‐dose nebulized budesonideActa Paediatrica, 1996
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.Thorax, 1995
- Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.Thorax, 1993
- Maturational delay and temporal growth retardation in asthmatic boysJournal of Allergy and Clinical Immunology, 1977